Zone-Specific PSA Density from AI-Assisted mp-MRI as a Predictor of Prostate Cancer in the PSA 4–20 ng/mL Range
Journal of Clinical Medicine · 23.07.2026 · 15 (15) · 5769
DOI: 10.3390/jcm15155769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.07.2026. Verfasst von Abdullah Golbasi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kayseri City Hospital, University of Health Sciences Medical Faculty of Kayseri, Kayseri 38280, Türkiye. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Serum prostate-specific antigen (PSA) lacks sufficient specificity for prostate cancer (PCa) detection. We evaluated the diagnostic value of AI-assisted MRI-derived zone-specific PSA density parameters, including transition zone PSA density (TZ-PSAD) and peripheral zone PSA density (PZ-PSAD), in men undergoing prostate biopsy.
Methods
This retrospective cohort study included 354 patients who underwent prostate biopsy due to elevated PSA (2024–2026), stratified into PSA 4–10 ng/mL (n = 272) and PSA 10–20 ng/mL (n = 82) groups. Zonal volumes were measured using AI-assisted mp-MRI segmentation per PI-RADS v2.1, and PSAD, TZ-PSAD, and PZ-PSAD were calculated accordingly. MRI readings were performed blinded to pathology.
Results
TZ-PSAD was significantly higher in PCa patients in both PSA groups (p < 0.001), demonstrating superior AUC compared to PSAD in both the PSA 4–10 ng/mL (0.711 vs. 0.660) and PSA 10–20 ng/mL (0.841 vs. 0.676) groups. At an optimal cut-off of ≥0.34 ng/mL2, TZ-PSAD yielded 44.8% sensitivity and 90.8% specificity in the PSA 4–10 group, improving to 73.8% sensitivity and 94.7% specificity at ≥0.48 ng/mL2 in the PSA 10–20 group. On multivariate analysis, TZ-PSAD and PI-RADS ≥ 3 emerged as independent predictors of PCa in both groups. Serum PSA, PZ-PSAD, and PZ volume failed to differentiate BPH from PCa in either group.
Conclusions
TZ-PSAD and conventional PSAD were both significantly associated with prostate cancer, whereas PZ-PSAD was not, and TZ-PSAD, combined with PI-RAD ≥3, emerged as an independent predictor in the PSA gray zone.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Kayseri City Hospital, University of Health Sciences Medical Faculty of Kayseri, Kayseri 38280, Türkiye.
- Department of Urology, Kayseri City Hospital, Kayseri 38280, Türkiye.
ORCID-Profile: Ali Yasin Ozercan
Zitieren
APA
Golbasi, A., Bicer, H., Ozercan, A. Y., Elmaagac, B., Sahin, O., & Karadag, M. A. (2026). Zone-Specific PSA Density from AI-Assisted mp-MRI as a Predictor of Prostate Cancer in the PSA 4–20 ng/mL Range. Journal of Clinical Medicine, 15(15), 5769. https://doi.org/10.3390/jcm15155769
Vancouver
Golbasi A, Bicer H, Ozercan AY, Elmaagac B, Sahin O, Karadag MA. Zone-Specific PSA Density from AI-Assisted mp-MRI as a Predictor of Prostate Cancer in the PSA 4–20 ng/mL Range. Journal of Clinical Medicine. 2026;15(15):5769. doi:10.3390/jcm15155769
BibTeX
@article{Golbasi2026,
author = {Golbasi, Abdullah and Bicer, Huseyin and Ozercan, Ali Yasin and Elmaagac, Burak and Sahin, Omer and Karadag, Mert Ali},
title = {Zone-Specific PSA Density from AI-Assisted mp-MRI as a Predictor of Prostate Cancer in the PSA 4–20 ng/mL Range},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5769},
doi = {10.3390/jcm15155769}
}
EUVIMED